Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
Customize your policy alerts
Sign up for all Oscar Health policy alerts
Know when Oscar Health releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage and limitations for serum biomarker and multianalyte panel testing used to evaluate and monitor hepatic fibrosis in individuals with chronic liver disease; it affects providers submitting claims to Oscar Health for these tests.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.